The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant versus adjuvant chemotherapy in muscle-invasive bladder cancer: The RealBLADDER study—Results on behalf of the GOIRC.
 
Elisabetta Gambale
No Relationships to Disclose
 
Roberta Giorgione
No Relationships to Disclose
 
Irene De Gennaro Aquino
No Relationships to Disclose
 
Federico Scolari
No Relationships to Disclose
 
Giandomenico Roviello
No Relationships to Disclose
 
Martina Catalano
No Relationships to Disclose
 
Marinella Micol Mela
No Relationships to Disclose
 
Laura Doni
No Relationships to Disclose
 
Mikol Modesti
No Relationships to Disclose
 
Ismaela Anna Vascotto
No Relationships to Disclose
 
Virginia Rossi
No Relationships to Disclose
 
Luca Galli
Expert Testimony - Bristol-Myers Squibb/Celgene; Janssen Oncology; MSD; Pfizer; Pfizer
 
Francesco Atzori
No Relationships to Disclose
 
Sarah Scagliarini
No Relationships to Disclose
 
Valentina Baldazzi
No Relationships to Disclose
 
Serena Pillozzi
No Relationships to Disclose
 
Cristina Masini
No Relationships to Disclose
 
Umberto Basso
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; AstraZeneca; Bristol-Myers Squibb; Pfizer
Research Funding - Ipsen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; ipsen; Janssen Oncology; Merck/Pfizer; MSD Oncology
Other Relationship - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Merck/Pfizer; MSD
 
Giuseppe Fornarini
No Relationships to Disclose
 
Lorenzo Antonuzzo
Honoraria - Amgen; AstraZeneca; Novartis; Roche
Consulting or Advisory Role - Merck Serono